FBRX
Forte Biosciences Inc
77.00$
+0.0%
vs. previous close
Closing price · As of: Aug 28, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | +0.0% | -100.0% | – | – | -100.0% | – | – | – | – | – | – | |
| – | +100.0% | +50.0% | +11.1% | +0.0% | +0.0% | +30.0% | +15.4% | +13.3% | -364.7% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -142.2% | – | – | |
| – | -44.0% | +22.0% | +31.9% | -0.3% | -8.6% | +139.8% | -31.3% | +74.6% | +42.4% | -5.2% | -99.3% | – | |
| – | -26.9% | +22.6% | +105.1% | -61.0% | -23.1% | +61.8% | -13.8% | +7.5% | -10.9% | -30.5% | +15.1% | – | |
| – | -37.6% | +22.3% | +64.3% | -32.7% | -14.8% | +119.5% | -28.2% | +58.8% | +34.0% | -8.8% | +9.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +0.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -130.1% | – | – | – | – | – | – | – | -64.0% | -48.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.